软骨下骨
骨关节炎
医学
骨重建
软骨
病理
成骨细胞
Wnt信号通路
病理生理学
炎症
转基因小鼠
骨细胞
前交叉韧带
阿达姆斯
癌症研究
骨量
内科学
关节软骨
作者
Weixin Xie,Antonia Donat,Shan Jiang,Haoyan Pan,Ruben Augustin,Till Schoberwalter,Chiara Gerriets,Jan Sevecke,Cordula Erdmann,Saskia Schröder,Assil‐Ramin Alimy,Isabell Behrens,Ana Ocokoljic,Wenbo Zhao,Julia Luther,Timur Alexander Yorgan,Thorsten Schinke,Karl-Heinz Frosch,Tim Rolvien,Anke Baranowsky
出处
期刊:Bone research
[Springer Nature]
日期:2026-11-20
卷期号:14 (1): 111-
标识
DOI:10.1038/s41413-026-00592-8
摘要
Despite mounting evidence emphasizing the role of abnormal subchondral bone remodeling in the progression of osteoarthritis (OA), clinical translation has produced disappointing results. Here, we demonstrate an increased expression of Wnt1, a key Wnt ligand with potent osteoanabolic effects, during OA progression in human and murine subchondral bone. Temporarily overexpressing Wnt1 in osteoblasts in the early phase after anterior cruciate ligament transection (ACLT)-induced OA has no effect on cartilage degeneration; however, it contributes to increased subchondral bone mass and alleviates subchondral bone loss. In contrast, late-phase induction of Wnt1 in osteoblasts exacerbates OA severity by inducing aberrant subchondral bone sclerosis, where inflammation-induced secreted frizzled-related protein 2 (Sfrp2) in the subchondral bone potentiates the harmful effects of Wnt1. Moreover, mice with a global inactivating Wnt1 G177C mutation, which clinically causes osteogenesis imperfecta type XV, display low subchondral bone mass, are resistant to ACLT-induced subchondral bone loss and exhibit attenuated OA progression. Taken together, these findings identify a pathophysiological role for Wnt1 in subchondral bone remodeling and OA progression that could represent a promising therapeutic target.
科研通智能强力驱动
Strongly Powered by AbleSci AI